Brain incretin signaling has emerged as a new field that might provide valuable contributions to the research of both the pathophysiology and, accordingly, novel therapeutic strategies in the treatment of diabetes, obesity, aging, and related neurodegenerative disorders. The gene discussed is GCG; the disease is Obesity.